Plimoth Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.61M Sell
31,130
-692
-2% -$161K 1.7% 12
2025
Q4
$6.59M Sell
31,822
-1,451
-4% -$287K 1.47% 14
2025
Q3
$6.17M Sell
33,273
-3,719
-10% -$637K 1.4% 15
2025
Q2
$5.65M Buy
36,992
+1,613
+5% +$248K 1.36% 15
2025
Q1
$5.87M Buy
35,379
+71
+0.2% +$11.1K 1.53% 12
2024
Q4
$5.11M Buy
35,308
+74
+0.2% +$11.5K 1.31% 17
2024
Q3
$5.71M Buy
35,234
+217
+0.6% +$34.6K 1.44% 18
2024
Q2
$5.12M Buy
35,017
+854
+2% +$127K 1.37% 18
2024
Q1
$5.4M Buy
34,163
+1,513
+5% +$241K 1.44% 17
2023
Q4
$5.12M Sell
32,650
-173
-0.5% -$26.5K 1.48% 18
2023
Q3
$5.11M Buy
32,823
+327
+1% +$54K 1.6% 14
2023
Q2
$5.38M Buy
32,496
+103
+0.3% +$16.6K 1.61% 14
2023
Q1
$5.02M Buy
32,393
+1,212
+4% +$196K 1.56% 15
2022
Q4
$5.51M Sell
31,181
-191
-0.6% -$33K 1.78% 9
2022
Q3
$5.13M Sell
31,372
-811
-3% -$137K 1.77% 10
2022
Q2
$5.71M Sell
32,183
-765
-2% -$136K 1.8% 9
2022
Q1
$5.84M Sell
32,948
-158
-0.5% -$26.9K 1.55% 12
2021
Q4
$5.66M Buy
33,106
+330
+1% +$54K 1.44% 13
2021
Q3
$5.29M Buy
32,776
+99
+0.3% +$16.9K 1.5% 13
2021
Q2
$5.38M Sell
32,677
-220
-0.7% -$36.4K 1.51% 13
2021
Q1
$5.41M Buy
32,897
+500
+2% +$80.9K 1.6% 14
2020
Q4
$5.1M Buy
32,397
+339
+1% +$50K 1.59% 13
2020
Q3
$4.77M Buy
32,058
+516
+2% +$76.4K 1.6% 12
2020
Q2
$4.44M Buy
31,542
+3,697
+13% +$539K 1.58% 13
2020
Q1
$3.65M Sell
27,845
-1,095
-4% -$155K 1.53% 13
2019
Q4
$4.22M Sell
28,940
-778
-3% -$106K 1.37% 15
2019
Q3
$3.85M Sell
29,718
-395
-1% -$52K 1.26% 16
2019
Q2
$4.19M Sell
30,113
-1,372
-4% -$190K 1.38% 16
2019
Q1
$4.4M Sell
31,485
-3,497
-10% -$468K 1.46% 16
2018
Q4
$4.51M Sell
34,982
-427
-1% -$59.6K 1.66% 13
2018
Q3
$4.89M Buy
35,409
+60
+0.2% +$7.97K 1.59% 14
2018
Q2
$4.29M Buy
35,349
+1,204
+4% +$150K 1.47% 15
2018
Q1
$4.38M Sell
34,145
-182
-0.5% -$24.6K 1.51% 13
2017
Q4
$4.8M Buy
+34,327
New +$4.78M 1.72% 11

Other funds holding JNJ

Plimoth Trust's JNJ Position: Q1 2026 in Review

Plimoth Trust reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, selling an estimated $161K and leaving 31,130 shares worth $7.61M. The position accounts for 1.7% of the portfolio, ranked #12.

Plimoth Trust first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Plimoth Trust held 31,130 shares of Johnson & Johnson worth $7.61M as of Q1 2026.
  • Plimoth Trust sold 692 Johnson & Johnson shares in Q1 2026, an estimated $161K.
  • Johnson & Johnson made up 1.7% of Plimoth Trust's portfolio in Q1 2026, its #12 holding.
  • Plimoth Trust first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.